Facial Expression Analysis System for Botulinum Toxin Dosing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for modulating facial expressions lack a comprehensive and functional approach to analyze, measure, and optimize the complex interactions and activations of facial expression markers and muscles, leading to unintended consequences and failure in effectively communicating psycho-physiological states.
Innovation Solution
A method involving the measurement and analysis of Facial Expression Activation Markers (FEAMs) and corresponding muscle activities to determine optimal patterns for desired facial expressions, using a SREDIC Intensity Scale and botulinum toxin treatment to selectively modulate facial features, ensuring balanced and functional mimetic differentiation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Shape
If botulinum toxin is applied to reduce hyperactive facial expression markers, then aesthetic appearance is improved, but functional communication may be compromised
Solution Approach 1:
The system applies different treatment intensities to different facial regions based on local analysis of hyperactivity patterns. Each facial marker receives customized botulinum toxin dosing according to its specific activation level and functional importance, rather than uniform treatment across the entire face.
Solution Approach 2:
The treatment planning system dynamically adjusts botulinum toxin dosing based on real-time analysis of facial marker activation patterns during multiple expressions. The system adapts treatment parameters to maintain functional ranges while reducing aesthetic concerns, allowing flexible optimization between appearance and communication functions.
2Manufacturing precision
If comprehensive analysis of multiple facial expressions is performed, then treatment optimization is improved, but system complexity increases
Solution Approach 1:
The facial analysis system divides the face into multiple discrete markers or regions of interest, each independently analyzed for activation patterns. This segmentation allows the complex overall facial expression analysis to be broken down into manageable local measurements, simplifying the computational task while maintaining comprehensive coverage.
Solution Approach 2:
The system performs preliminary capture and analysis of multiple facial expressions before treatment planning is finalized. By pre-analyzing activation patterns across various expressions, the system establishes baseline data that guides subsequent treatment decisions, reducing the complexity of real-time treatment optimization.
3Shape
If botulinum toxin dosage is increased to address hyperactive features, then aesthetic goals are achieved, but risk of over-treatment and frozen appearance increases
Solution Approach 1:
The system applies botulinum toxin at partial dosing levels targeted specifically at hyperactive facial markers rather than treating the entire face uniformly. By applying smaller, localized doses only where needed, the system achieves aesthetic improvement while minimizing the risk of over-treatment and frozen appearance.
Solution Approach 2:
The treatment planning system incorporates feedback from analyzed facial expression data to dynamically adjust botulinum toxin dosing levels. The system monitors activation patterns and uses this feedback to determine precise dosing that addresses hyperactivity while preserving functional expression ranges, preventing frozen appearance.
Data Source
AI summary
Apparatus and associated methods relate to method of determining a treatment plan with Botulinum Toxin (BT) and other procedures able to modify facial expressions, the method includes using a series of facial images of a patient eliciting various expressions to select individual expressive features as candidates for modification, the selected expressive features mapping to muscles that are used to create such expressive features, the muscles mapping into related expressive features of facial images of the patient eliciting different expressions, the related expressive features being weighted so as to provide further information used in determining an optimum treatment dosing for each treatment location. In an illustrative example, the method may include mapping the facial image of the patient to a model image using facial markers. In an exemplary embodiment, the method may advantageously provide a treatment that results in optimum expressive features as revealed in many different expressions.